Back to search

Institutional Repository of Vilnius University

XVII-osios Lietuvos Respublikos Vyriausybės vaistų kompensavimo reformos efektyvumo vertinimas /

Abstract

dc:description

The work assesses the 2017-2020 reform of reimbursable medicines in Lithuania by combining time-series financial data and legislative analysis. The reform has more than halved the average patient's prescription premium and increased the cost of medicines to the PSDF, but has been contained by tighter pricing and generic incentives. The extension of free medicines to seniors and low-income patients has reduced the risk of catastrophic health costs, and the 2021 Constitutional Court ruling has strengthened legal clarity. The case of Lithuania shows that a small market can reduce the financial burden on patients while maintaining budgetary sustainability.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Domarkas, Šarūnas,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Domarkas, Šarūnas,. XVII-osios Lietuvos Respublikos Vyriausybės vaistų kompensavimo reformos efektyvumo vertinimas /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD239018677&prefLang=en_US